MDR/IVDR
Table of Contents
Introduction
The Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) are key regulatory frameworks introduced by the European Union (EU) to ensure the safety, performance, and quality of medical devices and in vitro diagnostic devices. They are critical for companies engaged in manufacturing, distributing, or importing medical devices and diagnostics, and necessitate compliance to market these products in the EU.
Definitions and Concepts
- Medical Device Regulation (MDR): Regulation (EU) 2017/745 that governs the marketing and post-market surveillance of medical devices in the EU, ensuring their safety and performance.
- In Vitro Diagnostic Regulation (IVDR): Regulation (EU) 2017/746 designed to address the unique requirements for in vitro diagnostic devices, such as reagents and test kits.
- Notified Body: Independent organizations designated by EU member states to verify compliance with MDR and IVDR requirements.
- Clinical Evaluation: A systematic process to verify the safety and performance of a medical device based on clinical data.
- Risk Management: The continuous process of identifying, evaluating, and mitigating risks associated with a medical device.
Importance
Compliance with MDR and IVDR is crucial for accessing the EU market, a significant region for medical device and diagnostic sales. These regulations aim to enhance patient safety, promote innovation, and ensure consistent quality of medical devices and diagnostics. Moreover, non-compliance can result in legal penalties, product recalls, or access restrictions, which can impact a company’s reputation and profitability.
Key Principles and Requirements
- Stricter Classification Rules: Medical devices and diagnostics are classified into higher risk categories compared to previous regulations, necessitating more thorough assessments.
- Traceability: Implementation of the Unique Device Identification (UDI) system for better tracking of devices throughout their lifecycle.
- Clinical Data: Robust clinical evaluation for medical devices and performance evaluation for in vitro diagnostics are mandatory to demonstrate safety and effectiveness.
- Post-Market Surveillance (PMS): Manufacturers must have systems in place to monitor the safety and performance of their products after they are marketed.
- Technical Documentation: Detailed documentation demonstrating compliance is essential for regulatory audits and ongoing market authorization.
- Mandatory Notified Body Review: Higher scrutiny for device approvals, including those previously exempt under older rules.
Applications
MDR and IVDR impact a wide range of activities in the life sciences, pharmaceutical, and biotech sectors. For example:
- Device Manufacturers: Ensuring product designs and manufacturing processes meet updated regulatory standards.
- Clinical Laboratories: Adapting in vitro diagnostic procedures and validations to align with IVDR requirements.
- Pharmaceutical Companies: Collaboration with device manufacturers for combination products (e.g., drug-device combinations).
- Distributors and Importers: Verifying compliance of products before marketing them in the EU.
- Post-Market Surveillance Teams: Collecting and analyzing post-market risk data to fulfill PMS obligations.